Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Podcasts|February 8, 2012

Podcast: Using MRI in the Operating Room

Author(s)Sara Michael

Steven Kalkanis, MD, director of neurosurgical oncology at Henry Ford West Bloomfield Hospital, discusses how an MRI unit in the operating suite has transformed their approach to brain surgery.

 

[[{"type":"media","view_mode":"media_crop","fid":"11555","attributes":{"alt":"Kalkanis ","class":"media-image media-image-left","id":"media_crop_9093605711970","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"215","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 0px; float: left;","title":"","typeof":"foaf:Image"}}]]In the world of brain surgery, millimeters matter. Yet when an incision is made, the brain and fluid shifts, rendering pre-operative images less accurate for mapping the brain, said Steven Kalkanis, MD, co-director of the Hermelin Brain Tumor Center and director of neurosurgical oncology at Henry Ford West Bloomfield Hospital.

The solution? An MRI system in the operating suite that allows for mid-surgery scans for image-guided surgery. Henry Ford recently implemented an interoperative MRI suite that can provide more a precise, real-time picture of the brain.

“Being able to take these images as we are removing the tumor allows us to map and navigate and protect tissue that needs to be protected and remove malignant brain tissue,” Kalkanis said.

The technology has transformed the team’s approach to brain surgery. In this podcast, Kalkanis discusses the implications of this “game changer” technology and how they managed the implementation.

 

 

 

 

 

 

 

 

 

 
Dual-room suites for MR and surgery. Image courtesy Phillips


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Radiology and Building the Alzheimer’s Care Pathway of the Future
Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.